Gewinn- und Verlustrechnung von Albemarle Corporation

ALB is strengthening its balance sheet after $1.3 billion in debt repayment, cutting interest costs and boosting financial flexibility.

Albemarle (ALB) is now significantly down since our previous article in December 2025. ALB's proactive cost-cutting, asset sales, and capex reductions have strengthened its financial flexibility amid volatile lithium markets. Lithium demand remains robust, with battery storage and EV growth likely underestimated.

CHARLOTTE, N.C., Oct. 1, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its third quarter 2026 earnings after the NYSE closes on Wednesday, November 4, 2026.

Albemarle (ALB) closed the most recent trading day at $105.78, moving 1.71% from the previous trading session.

Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.

ALB and RIO ramp lithium strategies, highlighting growth plans, capacity expansion and rising demand from EV and storage markets.

Albemarle (NYSE: ALB - Get Free Report) and FUCHS (OTCMKTS:FUPBY - Get Free Report) are both materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends. Insider and Institutional Ownership 92.9% of Albemarle shares are owned

In the most recent trading session, Albemarle (ALB) closed at $108.25, indicating a -4.6% shift from the previous trading day.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Nykredit A S purchased a new position in shares of Albemarle Corporation (NYSE: ALB) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 430,222 shares of the specialty chemicals company's stock, valued at approximately $58,093,000. Nykredit A S owned about 0.36% of